[Form 4] Guardian Pharmacy Services, Inc. Insider Trading Activity
Thomas J. Salentine Jr., a director and reported >10% owner of Guardian Pharmacy Services, Inc. (GRDN), reported a Section 16 transaction on Form 4 showing activity on 09/27/2025. The filing discloses 6,100,176 shares of Class A common stock acquired (code M) and a disposition of 35,714 Class A shares. After the reported non-derivative transaction the filing shows 8,039,993 Class A shares beneficially owned indirectly through Bindley Capital Partners I, LLC. The filing also reports converted derivative/Class B activity reflecting 6,100,176 Class B shares treated as converted into Class A, bringing total indirect beneficial ownership of Class A to 12,200,350 shares. The filing notes these Class B shares convert one-for-one in tranches on 09/27/2025, 03/28/2026 and 09/27/2026.
Thomas J. Salentine Jr., direttore e proprietario >10% di Guardian Pharmacy Services, Inc. (GRDN), ha riportato una transazione di Sezione 16 sul Modulo 4 che mostra attività il 27/09/2025. La dichiarazione mostra 6.100.176 azioni ordinarie di Classe A acquisite (codice M) e una cessione di 35.714 azioni Classe A. Dopo la transazione non derivativa riportata, la dichiarazione mostra 8.039.993 azioni Classe A possedute beneficiariamente indirettamente tramite Bindley Capital Partners I, LLC. La dichiarazione riporta anche attività derivate/di Classe B convertite che indicano 6.100.176 azioni Classe B trattate come convertite in Classe A, portando la partecipazione indiretta totale in Classe A a 12.200.350 azioni. La dichiarazione nota che tali azioni Classe B si convertono una-per-una in tranche il 27/09/2025, il 28/03/2026 e il 27/09/2026.
Thomas J. Salentine Jr., director y titular >10% de Guardian Pharmacy Services, Inc. (GRDN), registró una transacción de la Sección 16 en el Formulario 4 que muestra actividad el 27/09/2025. La presentación divulga 6.100.176 acciones ordinarias de Clase A adquiridas (código M) y una disposición de 35.714 acciones de Clase A. Después de la transacción no derivativa reportada, la presentación muestra 8.039.993 acciones de Clase A beneficiadas de forma indirecta a través de Bindley Capital Partners I, LLC. La presentación también informa actividad derivada/Clase B convertida que refleja 6.100.176 acciones de Clase B tratadas como convertidas en Clase A, llevando la tenencia indirecta total de Clase A a 12.200.350 acciones. La presentación señala que estas acciones de Clase B se convierten una a una en tramos el 27/09/2025, el 28/03/2026 y el 27/09/2026.
Thomas J. Salentine Jr., Guardian Pharmacy Services, Inc. (GRDN)의 이사이자 >10% 보유자로, Form 4의 Section 16 거래를 2025-09-27에 보고했다. 제출 자료에는 6,100,176주 Class A 보통주를 취득(코드 M)했고 35,714주를 처분했다는 내용이 포함되어 있다. 보고된 비파생 거래 후 제출 자료는 Bindley Capital Partners I, LLC를 통해 간접적으로 보유하는 Class A 주식이 8,039,993주로 기재된다. 또한 변형파생/Classe B 활동이 Class B 주식 6,100,176주가 Class A로 1대 1로 전환된 것으로 반영되어 Class A의 간접 보유 총주식 수가 12,200,350주로 증가한다는 것도 보고된다. 이 Classe B 주식은 2025-09-27, 2026-03-28, 2026-09-27에 걸쳐 1대 1로 전환된다고 명시된다.
Thomas J. Salentine Jr., directeur et détenteur >10% de Guardian Pharmacy Services, Inc. (GRDN), a signalé une transaction de la Section 16 sur le Formulaire 4 indiquant une activité le 27/09/2025. Le dossier vocale 6 100 176 actions ordinaires de Classe A acquises (code M) et une cession de 35 714 actions Classe A. Après la transaction non dérivée reportée, le dossier indique 8 039 993 actions Classe A détenues bénéficiellement indirectement par Bindley Capital Partners I, LLC. Le dossier signale également une activité dérivée/Classe B convertie reflétant 6 100 176 actions Classe B considérées comme converties en Classe A, portant la possession indirecte totale de Classe A à 12 200 350 actions. Le dossier indique que ces actions Classe B se convertissent une par une par tranches le 27/09/2025, le 28/03/2026 et le 27/09/2026.
Thomas J. Salentine Jr., Direktor und >10% Eigentümer von Guardian Pharmacy Services, Inc. (GRDN), meldete eine Section-16-Transaktion im Formular 4 mit Aktivität am 27.09.2025. Die Einreichung gibt 6.100.176 Class-A-Stammaktien an, die erworben wurden (Code M), sowie eine Veräußerung von 35.714 Class-A-Aktien an. Nach der berichteten Nicht-Derivattransaktion zeigt die Einreichung 8.039.993 Class-A-Aktien, die indirekt über Bindley Capital Partners I, LLC gehalten werden. Die Einreichung berichtet außerdem konvertierte Derivate/Class-B-Aktivität, die 6.100.176 Class-B-Aktien betreffen, die als in Class A konvertiert behandelt werden, womit der gesamte indirekte Besitz von Class A auf 12.200.350 Aktien ansteigt. Die Einreichung vermerkt, dass diese Class-B-Aktien eins-zu-eins in Tranchen am 27.09.2025, am 28.03.2026 und am 27.09.2026 konvertiert werden.
Thomas J. Salentine Jr.، مدير ومالك يزيد على 10% من Guardian Pharmacy Services, Inc. (GRDN)، أبلغ عن معاملة القسم 16 في النموذج 4 التي تُظهر نشاطاً في 27/09/2025. تُظهر الإيداع 6,100,176 سهماً عائداً فئة أ مكتسبة (رمز M) وتصفية لـ 35,714 من أسهم الفئة أ. بعد المعاملة غير المشتقة المذكورة، يُظهر الإيداع 8,039,993 سهماً من الفئة أ مملوكاً للمستفيد بشكل غير مباشر من خلال Bindley Capital Partners I, LLC. كما يذكر الإيداع نشاطاً مشتقّاً/فئة B محولاً يعكس 6,100,176 سهماً من فئة B تعتبر محوّلة إلى فئة A، مما يرفع الملكية غير المباشرة الإجمالية من فئة A إلى 12,200,350 سهماً. كما يُشير الإيداع إلى أن هذه الأسهم من فئة B تتحول واحداً مقابل واحد على شكل دفعات في 27/09/2025، و28/03/2026، و27/09/2026.
Thomas J. Salentine Jr.，Guardian Pharmacy Services, Inc.（GRDN）的董事且>10%所有者，在 Form 4 的第16条交易中报告了活动，日期为 2025-09-27。申报披露6,100,176股A类普通股已取得（代码 M），并处置了35,714股A类股。该非衍生交易后，申报显示通过 Bindley Capital Partners I, LLC 间接拥有的A类股为8,039,993股。申报还报告了将6,100,176股B类衍生品/股票视为转换为A类的转化性活动，使A类的间接控股总数增至12,200,350股。申报指出这些B类股票将于2025-09-27、2026-03-28和2026-09-27按一对一的比例分批转换。
- Transaction disclosed transparently with clear dates and post-transaction beneficial ownership totals
- Conversion follows chartered mechanism (one-for-one tranches) so change is procedural and disclosed
- No pricing or cash consideration provided for the transaction, limiting assessment of economic impact
- Large indirect ownership concentration (12,200,350 Class A shares) could affect float or control dynamics
Insights
TL;DR: Significant insider conversion increases Class A shares controlled indirectly via Bindley Capital, altering public float composition.
The Form 4 documents a sizeable one-time conversion event:The reporting person, identified as a director and >10% owner, recorded acquisition of 6,100,176 Class A shares (transaction code M) and a small 35,714 share disposition. The filing explicitly states these Class B shares convert one-for-one into Class A in scheduled tranches, and post-transaction beneficial ownership totals are disclosed. This is a material ownership reclassification that increases indirect Class A holdings to 12,200,350 shares. The disclosure is factual and limited to ownership change; no sales, option exercises for cash, or pricing information beyond the transaction codes are provided.
TL;DR: Conversion follows charter terms; increases voting/ownership exposure in Class A for an insider entity.
The filing explicitly ties the share movement to the Issuer's Amended and Restated Certificate of Incorporation, stating scheduled automatic conversions of Class B to Class A. The reporting person holds the converted shares indirectly through Bindley Capital Partners I, LLC. This is a governance-driven reclassification rather than a market sale and should be viewed as a transfer of economic or voting exposure from Class B to Class A per the charter mechanics described in the filing. The form contains no indications of changes to voting rights beyond the conversion mechanics stated.
Thomas J. Salentine Jr., direttore e proprietario >10% di Guardian Pharmacy Services, Inc. (GRDN), ha riportato una transazione di Sezione 16 sul Modulo 4 che mostra attività il 27/09/2025. La dichiarazione mostra 6.100.176 azioni ordinarie di Classe A acquisite (codice M) e una cessione di 35.714 azioni Classe A. Dopo la transazione non derivativa riportata, la dichiarazione mostra 8.039.993 azioni Classe A possedute beneficiariamente indirettamente tramite Bindley Capital Partners I, LLC. La dichiarazione riporta anche attività derivate/di Classe B convertite che indicano 6.100.176 azioni Classe B trattate come convertite in Classe A, portando la partecipazione indiretta totale in Classe A a 12.200.350 azioni. La dichiarazione nota che tali azioni Classe B si convertono una-per-una in tranche il 27/09/2025, il 28/03/2026 e il 27/09/2026.
Thomas J. Salentine Jr., director y titular >10% de Guardian Pharmacy Services, Inc. (GRDN), registró una transacción de la Sección 16 en el Formulario 4 que muestra actividad el 27/09/2025. La presentación divulga 6.100.176 acciones ordinarias de Clase A adquiridas (código M) y una disposición de 35.714 acciones de Clase A. Después de la transacción no derivativa reportada, la presentación muestra 8.039.993 acciones de Clase A beneficiadas de forma indirecta a través de Bindley Capital Partners I, LLC. La presentación también informa actividad derivada/Clase B convertida que refleja 6.100.176 acciones de Clase B tratadas como convertidas en Clase A, llevando la tenencia indirecta total de Clase A a 12.200.350 acciones. La presentación señala que estas acciones de Clase B se convierten una a una en tramos el 27/09/2025, el 28/03/2026 y el 27/09/2026.
Thomas J. Salentine Jr., Guardian Pharmacy Services, Inc. (GRDN)의 이사이자 >10% 보유자로, Form 4의 Section 16 거래를 2025-09-27에 보고했다. 제출 자료에는 6,100,176주 Class A 보통주를 취득(코드 M)했고 35,714주를 처분했다는 내용이 포함되어 있다. 보고된 비파생 거래 후 제출 자료는 Bindley Capital Partners I, LLC를 통해 간접적으로 보유하는 Class A 주식이 8,039,993주로 기재된다. 또한 변형파생/Classe B 활동이 Class B 주식 6,100,176주가 Class A로 1대 1로 전환된 것으로 반영되어 Class A의 간접 보유 총주식 수가 12,200,350주로 증가한다는 것도 보고된다. 이 Classe B 주식은 2025-09-27, 2026-03-28, 2026-09-27에 걸쳐 1대 1로 전환된다고 명시된다.
Thomas J. Salentine Jr., directeur et détenteur >10% de Guardian Pharmacy Services, Inc. (GRDN), a signalé une transaction de la Section 16 sur le Formulaire 4 indiquant une activité le 27/09/2025. Le dossier vocale 6 100 176 actions ordinaires de Classe A acquises (code M) et une cession de 35 714 actions Classe A. Après la transaction non dérivée reportée, le dossier indique 8 039 993 actions Classe A détenues bénéficiellement indirectement par Bindley Capital Partners I, LLC. Le dossier signale également une activité dérivée/Classe B convertie reflétant 6 100 176 actions Classe B considérées comme converties en Classe A, portant la possession indirecte totale de Classe A à 12 200 350 actions. Le dossier indique que ces actions Classe B se convertissent une par une par tranches le 27/09/2025, le 28/03/2026 et le 27/09/2026.
Thomas J. Salentine Jr., Direktor und >10% Eigentümer von Guardian Pharmacy Services, Inc. (GRDN), meldete eine Section-16-Transaktion im Formular 4 mit Aktivität am 27.09.2025. Die Einreichung gibt 6.100.176 Class-A-Stammaktien an, die erworben wurden (Code M), sowie eine Veräußerung von 35.714 Class-A-Aktien an. Nach der berichteten Nicht-Derivattransaktion zeigt die Einreichung 8.039.993 Class-A-Aktien, die indirekt über Bindley Capital Partners I, LLC gehalten werden. Die Einreichung berichtet außerdem konvertierte Derivate/Class-B-Aktivität, die 6.100.176 Class-B-Aktien betreffen, die als in Class A konvertiert behandelt werden, womit der gesamte indirekte Besitz von Class A auf 12.200.350 Aktien ansteigt. Die Einreichung vermerkt, dass diese Class-B-Aktien eins-zu-eins in Tranchen am 27.09.2025, am 28.03.2026 und am 27.09.2026 konvertiert werden.
FAQ
What did Thomas J. Salentine Jr. report on Form 4 for GRDN?
How many Class A shares does the filing show beneficially owned after the transaction?
Why were Class B shares converted to Class A according to the filing?
Is the reported ownership direct or indirect?
Does the Form 4 disclose any cash proceeds or prices for the converted shares?
